Aktie A2PWNG NEMAURA MEDICAL INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Nemaura Medical Inc.

Aktien

A2PWNG

US6404422080

NMRD

Markt geschlossen - OTC Markets
Andere Börsenplätze
 19:57:10 03.05.2024 		% 5 Tage % 1. Jan.
0.043 USD +11.70% Intraday Chart für Nemaura Medical Inc. -20.66% -80.37%
10.04. Nemaura Medical Inc. kündigt Änderungen im Vorstand an CI
12.02. Nemaura Medical Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Dezember 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Nemaura Medical : Certificate of Incorporation/Bylaws - Form 8-K
Nemaura Medical Inc. Announces Board Changes
Nemaura Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Nemaura Medical Inc.(OTCPK:NMRD) dropped from S&P TMI Index
Nemaura Medical Inc. - Important Update on Listing Status and Strategic Direction
Nemaura Medical Inc.(OTCPK:NMRD) dropped from NASDAQ Composite Index
Important Update on Listing Status and Strategic Direction
Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision
Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth
Nemaura Medical Rolls Out Metabolic Health Program in UK
Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs
Nemaura Medical Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs
Nemaura Medical Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update
Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs.
Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference
Nemaura Medical Says Nasdaq Listing Standards Probably Won't Be Met by Deadline
Nemaura Medical Provides Update on Nasdaq Compliance Status and Process
Top Penny Stock Gainers Momentum Watchlist (ORHB, GSAC, NMRD, SASI)
Nemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss Program
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2PWNG Aktie
  4. Nachrichten Nemaura Medical Inc.
  5. Andere Sprachen